Literature DB >> 12651261

Prevalence of C282Y and E168X HFE mutations in an Italian population of Northern European ancestry.

Alessandra Salvioni1, Raffaella Mariani, Christian Oberkanins, Anne Moritz, Viviana Mauri, Sara Pelucchi, Alessia Riva, Cristina Arosio, Paolo Cerutti, Alberto Piperno.   

Abstract

BACKGROUND AND OBJECTIVES: In Italy, the prevalence of C282Y is lower than in Northern European countries. We hypothesized a higher prevalence of C282Y in Northern than in Southern Italian populations. We previously identified a nonsense mutation (E168X) in hemochromatosis probands originating from a region in the north-west of Italy. We aimed to define the prevalence of C282Y and E168X in that region and the origin of the E168X mutation by haplotype analysis. DESIGN AND METHODS: Six-hundred and six blood donors were investigated for C282Y, H63D, S65C and E168X mutations by polymerase chain reaction (PCR)-restriction assays. Three hundred were also tested for rare HFE and TFR2 mutations by reverse-hybridization test strips. D6S265, D6S105 and D6S1281 microsatellites were analyzed to define E168X 6p-associated haplotypes.
RESULTS: One C282Y homozygote, thirteen C282Y/ H63D compound heterozygotes, four E168X heterozygotes and three E168X/H63D compound heterozygotes were found. The allele frequencies of C282Y, H63D, S65C, and E168X were 4.7%, 14.9%, 0.74% and 0.58%, respectively. INTERPRETATION AND
CONCLUSIONS: The prevalence of C282Y in the region investigated was much higher than that previously reported in Italy. This finding is probably due to the heavy Celtic component of this north-western population and suggests that in populations of Northern Italian descent screening studies for hemochromatosis could be cost-effective. The prevalence of E168X in this region, although low, suggests that the mutation probably originated here many years ago and its frequency increased as a result of a local founder effect. Given its severity, we suggest that the E168X mutation should be searched for in all hemochromatosis patients of Northern ancestry with an incomplete HFE genotype.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12651261

Source DB:  PubMed          Journal:  Haematologica        ISSN: 0390-6078            Impact factor:   9.941


  3 in total

1.  Analysis of HFE genes C282Y, H63D, and S65D in patients with hyperferritinemia from northeastern Brazil.

Authors:  Gioconda Dias Rodrigues Leão; Juliana Mendonça Freire; Andrea Luciana Araújo Cunha Fernandes; Taissa Maria Moura de Oliveira; Nilma Dias Leão; Erica Aires Gil; Roberto Chaves de Vasconcelos; João Paulo da Silva Azevedo; Valéria Soraya de Farias Sales; Telma Maria de Araújo Moura Lemos; Marcos Dias Leão; Francisco Fernandes do Nascimento; James Farley Rafael Maciel; Rodrigo Villar de Freitas; Aldair de Souza Paiva; Geraldo Barroso Cavalcanti
Journal:  J Clin Lab Anal       Date:  2014-01-06       Impact factor: 2.352

2.  Analysis of HFE and non-HFE gene mutations in Brazilian patients with hemochromatosis.

Authors:  Paulo Lisboa Bittencourt; Maria Lúcia Carnevale Marin; Cláudia Alves Couto; Eduardo Luiz Rachid Cançado; Flair José Carrilho; Anna Carla Goldberg
Journal:  Clinics (Sao Paulo)       Date:  2009       Impact factor: 2.365

3.  Prevalence of H63D, S65C and C282Y hereditary hemochromatosis gene mutations in Slovenian population by an improved high-throughput genotyping assay.

Authors:  Marko Cukjati; Tomaz Vaupotic; Ruth Rupreht; Vladka Curin-Serbec
Journal:  BMC Med Genet       Date:  2007-11-23       Impact factor: 2.103

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.